Glaxo halves price of AIDS drug for poor
Glaxosmithkline Plc, the world's largest maker of HIV/AIDS drugs, said it had cut the price of its leading Combivir treatment in poor countries by 47% to under $1 a day. The move is the latest sign
Glaxosmithkline Plc, the world's largest maker of HIV/AIDS drugs, said it had cut the price of its leading Combivir treatment in poor countries by 47% to under $1 a day. The move is the latest sign